Vascular Risk Factors and Cognition in Parkinson’s Disease
Andrea Pilotto(Fondazione Europea Ricerca Biomedica), Alessandro Padovani(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Loris Poli(Anna Needs Neuroblastoma Answers), Enrico Premi(Anna Needs Neuroblastoma Answers), Maura Cosseddu(University of Brescia), Barbara Bigni(University of Brescia), Anna Maria Formenti(University of Brescia), Rosanna Turrone(University of Brescia), Antonella Alberici(Anna Needs Neuroblastoma Answers), Inga Liepelt‐Scarfone(German Center for Neurodegenerative Diseases), Marta Bianchi(University of Brescia), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Barbara Borroni(Centro San Giovanni di Dio Fatebenefratelli), Elisabetta Cottini(Anna Needs Neuroblastoma Answers)
Cited by 60
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846